Vol 8, No 4 (2023)
Case report
Published online: 2023-10-13

open access

Page views 660
Article views/downloads 274
Get Citation

Connect on Social Media

Connect on Social Media

Graft loss from a living donor due to flash recurrence of focal segmental glomerular sclerosis — case report

Marta Głuchowska1, Łukasz Gawlik2, Azita Razaei3, Marcin Gregorczyk3, Piotr Jagodowski2, Paweł Wróbel45
Medical Research Journal 2023;8(4):317-319.

Abstract

Focal segmental glomerular sclerosis is a pattern of histological damage of the kidney. The most common clinical manifestation is proteinuria, however, it can frequently progress to full nephrotic syndrome. Glucocorticosteroids are the first line of treatment and, in case of resistance, calcineurin inhibitors are used. In some patients, despite treatment, focal segmental glomerular sclerosis leads to end-stage renal disease, in which organ transplantation is the only therapeutic option. In several cases, relapse occurs in the transplanted organ. The following paper presents a case report of a patient treated for focal segmental glomerular sclerosis since the age of 21, who developed end-stage renal failure after seven years of disease despite immunosuppressive treatment. Although there was a significant risk of recurrence, it was decided to transplant a kidney from a family donor — the patient’s mother. From about one week after transplantation, progressive deterioration of graft function was observed.

Article available in PDF format

View PDF Download PDF file

References

  1. De Vriese AnS, Wetzels JF, Glassock RJ, et al. Therapeutic trials in adult FSGS: lessons learned and the road forward. Nat Rev Nephrol. 2021; 17(9): 619–630.
  2. Klinger M, Perkowska-Ptasińska A. Ogniskowe segmentowe stwardnienie kłębuszków nerkowych. Nefrol Dial Pol. 2016; 20: 48–53.
  3. Shabaka A, Tato Ribera A, Fernández-Juárez G. Focal segmental glomerulosclerosis: state-of-the-art and clinical perspective. Nephron. 2020; 144(9): 413–427.
  4. Dêborska-Materkowska D, Durlik M. Nawrót FSGS w nerce przeszczepionej. Postępy Nauk Med. 2010; XXIII(3): 238–246.
  5. Sprangers B, Meijers B, Appel G. FSGS: diagnosis and diagnostic work-up. Biomed Res Int. 2016; 2016: 4632768.
  6. Politano SA, Colbert GB, Hamiduzzaman N. Nephrotic syndrome. Prim Care. 2020; 47(4): 597–613.
  7. Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021; 100(4): 753–779.
  8. First MR. Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis. Pediatr Nephrol. 1995; 9 Suppl: S40–S42.
  9. Uffing A, Pérez-Sáez MJ, Mazzali M, et al. Recurrence of FSGS after kidney transplantation in adults. Clin J Am Soc Nephrol. 2020; 15(2): 247–256.
  10. Winn MP, Alkhunaizi AM, Bennett WM, et al. Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis. 1999; 33(5): 970–974.
  11. Akioka K, Okamoto M, Wakabayashi Y, et al. Long-term outcome of renal transplantation in focal glomerulosclerosis. Transplant Proc. 2006; 38(9): 2819–2822.
  12. Durlik M, Klinger M. Chory dializowany jako biorca przeszczepu. Renal Dis Transplant Forum. 2010; 3(3): 201–211.
  13. Lentine KL, Lam NN, Segev DL. Risks of living kidney donation: current state of knowledge on outcomes important to donors. Clin J Am Soc Nephrol. 2019; 14(4): 597–608.